Literature DB >> 35834057

Sex-Dependent Alterations in the mRNA Expression of Enzymes Involved in Dopamine Synthesis and Breakdown After Methamphetamine Self-Administration.

Aaron E Miller1, Atul P Daiwile1, Jean Lud Cadet2.   

Abstract

Sex differences have been reported in methamphetamine (METH) use disorder in humans and in animal models of METH exposure. Specifically, animals that self-administer METH show sex-related dissimilarities in dopamine (DA) metabolism. To better understand the molecular bases for the differences in DA metabolism, we measured the levels of mRNAs of enzymes that catalyze DA synthesis and breakdown in the prefrontal cortex (PFC), nucleus accumbens (NAc), dorsal striatum (dSTR), and hippocampus (HIP) of rats that had self-administered METH. There were significant sex differences in control rats, with males having higher basal levels of Th in the PFC and dSTR, Ddc in the NAc, and MaoB in the HIP. In contrast, female controls showed higher basal levels of Comt in the HIP. Male and female METH SA rats also showed some distinct responses to the drug. Specifically, female METH rats exhibited increased expression of Ddc and MaoB, whereas male METH animals showed higher levels of Comt mRNA in the PFC compared to their respective controls. In the NAc, male METH rats displayed decreased Th and Ddc mRNA levels. Together, our results identified sex-dependent and region-specific changes in the mRNA expression of several enzymes involved in DA synthesis and breakdown in response to METH SA, with the majority of differences being observed in the mesocorticolimbic dopaminergic system. These findings are of significant translational importance providing further support for the inclusion of sex as an important variable when planning and evaluating therapeutic interventions against METH use disorder in human clinical studies.
© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Entities:  

Keywords:  Catechol-O-methyltransferase; Dopa-decarboxylase; Dopamine metabolism; Methamphetamine; Monoamine oxidase; Tyrosine hydroxylase

Mesh:

Substances:

Year:  2022        PMID: 35834057     DOI: 10.1007/s12640-022-00545-z

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.978


  68 in total

1.  Sex and temporally-dependent effects of methamphetamine toxicity on dopamine markers and signaling pathways.

Authors:  Mélanie Bourque; Dean E Dluzen; Thérèse Di Paolo
Journal:  Neuropharmacology       Date:  2012-02-21       Impact factor: 5.250

2.  Sex differences in methamphetamine toxicity in mice: effect on brain dopamine signaling pathways.

Authors:  Mélanie Bourque; Bin Liu; Dean E Dluzen; Thérèse Di Paolo
Journal:  Psychoneuroendocrinology       Date:  2011-01-13       Impact factor: 4.905

3.  Optogenetic inhibition of the medial prefrontal cortex reduces methamphetamine-primed reinstatement in male and female rats.

Authors:  Rebecca Cordie; Lisa M McFadden
Journal:  Behav Pharmacol       Date:  2019-09       Impact factor: 2.293

Review 4.  Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system.

Authors:  M Amalric; G F Koob
Journal:  Prog Brain Res       Date:  1993       Impact factor: 2.453

Review 5.  Role of Dopamine Signaling in Drug Addiction.

Authors:  Wan Chen; Zhihuan Nong; Yaoxuan Li; Jianping Huang; Chunxia Chen; Luying Huang
Journal:  Curr Top Med Chem       Date:  2017       Impact factor: 3.295

6.  Neurochemical characterization of dopaminergic neurons in human striatum.

Authors:  Martine Cossette; Daniel Lévesque; André Parent
Journal:  Parkinsonism Relat Disord       Date:  2005-08       Impact factor: 4.891

7.  Methamphetamine preconditioning: differential protective effects on monoaminergic systems in the rat brain.

Authors:  Jean Lud Cadet; Irina N Krasnova; Bruce Ladenheim; Ning-Sheng Cai; Michael T McCoy; Fidelis E Atianjoh
Journal:  Neurotox Res       Date:  2009-02-24       Impact factor: 3.911

8.  Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice.

Authors:  J L Cadet; P Sheng; S Ali; R Rothman; E Carlson; C Epstein
Journal:  J Neurochem       Date:  1994-01       Impact factor: 5.372

9.  Sex differences in methamphetamine seeking in rats: impact of oxytocin.

Authors:  Brittney M Cox; Amy B Young; Ronald E See; Carmela M Reichel
Journal:  Psychoneuroendocrinology       Date:  2013-06-12       Impact factor: 4.905

Review 10.  Monoamine oxidase inactivation: from pathophysiology to therapeutics.

Authors:  Marco Bortolato; Kevin Chen; Jean C Shih
Journal:  Adv Drug Deliv Rev       Date:  2008-07-04       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.